WHO Prequalification of Medicines Programme position on US FDA actions against Ranbaxy
M
As changes in manufacturing sites and activities on sites may change, it is suggested that all users of the list of prequalified products and WHOPIRs verify with the manufacturers
see also: WHO Media Centre: http://www.who.int/entity/mediacentre/news/notes/2005/n
WHO News Release WHO/87, WHO Geneva.
WHO, Geneva.
WHO Geneva.
WHO Geneva. Department of Essential Drugs and Medicines Policy; Department of HIV/AIDS